Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMorphoSys Ag Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
MorphoSys Ag Earnings Date And Information
MorphoSys Ag last posted its earnings results on Thursday, August 29th, 2024. The company reported $-0.59 earnings per share for the quarter, topping analysts' consensus estimates of $-1.33 by $0.74. The company had revenue of 27.54 M for the quarter and had revenue of 238.28 M for the year. MorphoSys Ag has generated $-1 earnings per share over the last year ($-1.38 diluted earnings per share) and currently has a price-to-earnings ratio of -12.05. MorphoSys Ag has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
MorphoSys Ag Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/30/2024 | Q1 2024 | N/A | -$2.07 | N/A | $27.54 M | $27.54 M |
| 03/13/2024 | Q4 2023 | $0.08 | $0.32 | 0.24 | $64.11 M | $59.08 M |
| 11/16/2023 | Q3 2023 | N/A | -$0.87 | N/A | $61.72 M | $63.80 M |
| 06/30/2023 | Q2 2023 | N/A | -$0.54 | N/A | $59.28 M | $53.17 M |
| 05/04/2023 | Q1 2023 | N/A | -$0.23 | N/A | $45.55 M | $62.32 M |
| 03/15/2023 | Q4 2022 | -$0.42 | $2.41 | 2.83 | $53.75 M | $81.67 M |
| 11/16/2022 | Q3 2022 | -$0.39 | -$0.90 | -0.51 | $56.77 M | $95.70 M |
| 06/30/2022 | Q2 2022 | N/A | -$1.72 | N/A | $61.22 M | $59.44 M |
| 06/23/2022 | Q1 2022 | N/A | -$0.90 | N/A | $51.61 M | $41.50 M |
| 03/16/2022 | Q4 2021 | N/A | -$2.79 | N/A | $46.53 M | $52.90 M |
| 09/30/2021 | Q3 2021 | N/A | -$0.82 | N/A | $45.12 M | $41.24 M |
| 07/28/2021 | Q2 2021 | -$0.47 | $0.16 | 0.63 | $41.40 M | $38.20 M |
| 03/31/2021 | Q1 2021 | N/A | -$0.32 | N/A | $54.16 M | $47.19 M |
| 03/15/2021 | Q4 2020 | -$0.57 | -$0.12 | 0.45 | $33.57 M | $36.04 M |
| 09/30/2020 | Q3 2020 | N/A | -$0.50 | N/A | $24.21 M | $22.00 M |
| 08/05/2020 | Q2 2020 | -$2.00 | -$0.40 | 1.6 | $12.43 M | $18.43 M |
| 03/31/2020 | Q1 2020 | N/A | $1.82 | N/A | $201.73 M | $251.22 M |
| 03/18/2020 | Q4 2019 | N/A | -$0.40 | N/A | $12.39 M | $11.08 M |
| 09/30/2019 | Q3 2019 | N/A | -$0.19 | N/A | $19.18 M | $12.47 M |
| 08/08/2019 | Q2 2019 | -$0.27 | -$0.05 | 0.22 | $11.69 M | $34.66 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MorphoSys Ag Earnings: FAQ's
In the previous quarter, MorphoSys Ag (:MOR) reported $-0.59 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.33 by $0.74.
The conference call for MorphoSys Ag's latest earnings report can be listened to online.
The conference call transcript for MorphoSys Ag's latest earnings report can be read online.
MorphoSys Ag (:MOR) has a recorded annual revenue of $238.28 M.
MorphoSys Ag (:MOR) has a recorded net income of $-189,734,199.MorphoSys Ag has generated $-1.38 earnings per share over the last four quarters.
MorphoSys Ag (:MOR) has a price-to-earnings ratio of -12.05 and price/earnings-to-growth ratio is -0.08.